Medicare costs are projected to rise by their highest amount in years. Here’s what to expect if you’re on Part B or Part D.

Recent reports have stirred concerns about the future of Aetna's Medicare Advantage plans. Allegations suggest a significant ...

Millions of Americans aged 65 and older rely on Medicare Part D to manage the cost of their prescription medications. As the healthcare landscape shifts, this crucial benefit faces financial and ...

Headline profit and GAAP EPS of $1.71 for Q2 2025 resulted almost entirely from a one-time asset sale rather than ongoing business operations. Q2 2025 marked the first revenue recognition ($0.4 ...

Chicago-based GoHealth announced a series of financing and leadership changes aimed at strengthening its position as a health ...

After four years at the helm of Enhabit Inc. (NYSE: EHAB), CEO Barb Jacobsmeyer is departing from the company amid what she ...

Healthcare services company Agilon Health (NYSE:AGL) missed Wall Street’s revenue expectations in Q2 CY2025, with sales ...

Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.

STRATA Skin Sciences(NASDAQ:SSKN) reported its second-quarter 2025 results on August 13, 2025, highlighting significant developments in reimbursement expansion, ongoing litigation, and commercial ...

The Centers for Medicare & Medicaid Services (CMS) on July 31, 2025, issued the final rule to update Medicare payment policies and rates for ...

CMS’ recent proposal to phase out the inpatient-only list is drawing mixed reactions from healthcare leaders. As part of the Outpatient Prospective Payment System proposed rule for 2026, the agency ...

UnitedHealth's modest valuation, strong fundamentals, and recovery potential by 2027 make UNH stock a Buy for patient ...